Braña M F, Castellano J M, Keilhauer G, Machuca A, Martín Y, Redondo C, Schlick E, Walker N
Laboratorios Knoll S.A., Madrid, Spain.
Anticancer Drug Des. 1994 Dec;9(6):527-38.
A series of substituted benzimidazo[1,2-c]quinazolines have been synthesized. This class of compound has been designed by structural comparison with other intercalator patterns. The determination of in vitro activities has shown high inhibitory values.
一系列取代苯并咪唑并[1,2-c]喹唑啉已被合成。这类化合物是通过与其他嵌入剂模式进行结构比较设计出来的。体外活性测定显示出较高的抑制值。